Key facts
- This page summarizes VIKING GLOBAL INVESTORS LP's Form 4 filing for Amylyx Pharmaceuticals, Inc. (AMLX).
- 16 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Sep 2022, 21:48.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Additional SEC filing notes
Section 16 status
VIKING GLOBAL INVESTORS LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP ("VGI") and Viking Global Opportunities Parent GP LLC ("Parent"), which is the sole member of Viking Global Opportunities GP LLC ("Opportunities GP"), which is the sole member of Viking Global Opportunities Portfolio GP LLC ("Opportunities Portfolio GP"). VGI provides managerial services to various investment funds and vehicles, including Viking Global Opportunities Illiquid Investments Sub-Master LP ("Opportunities Fund") and DRAGSA 96 LLC ("DRAGSA 96"). Each of VGI, Parent, Opportunities GP, Mr. Halvorsen, Mr. Ott and Ms. Shabet (collectively the "Reporting Persons") may be deemed to beneficially own all of the securities reported on this form.
Footnote F2
These shares are held directly by Opportunities Fund. Because of the relationship between VGI and Opportunities Fund, VGI may be deemed to beneficially own the shares held directly by Opportunities Fund.
Footnote F3
Parent is the general partner of Opportunities GP. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund. Because of the relationship between Parent, Opportunities GP, Opportunities Portfolio GP and Opportunities Fund, each of Parent, Opportunities GP and Opportunities Portfolio GP may be deemed to beneficially own the shares held directly by Opportunities Fund.
Footnote F4
The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
Footnote F5
These shares are held directly by DRAGSA 96. Because of the relationship between VGI and DRAGSA 96, VGI may be deemed to beneficially own the shares held directly by DRAGSA 96.
Footnote F6
The membership interests of DRAGSA 96 are held by Viking Global Opportunities Intermediate LP and Viking Global Opportunities LP. Opportunities GP is the general partner of Viking Global Opportunities Intermediate LP and Viking Global Opportunities LP. Because of the relationship between Parent, Opportunities GP and DRAGSA 96, each of Parent and Opportunities GP may be deemed to beneficially own the shares of Common Stock held directly by DRAGSA 96.
Footnote F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.00 to $27.85. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (7) through (14) of this Form 4.
Footnote F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.465.
Footnote F9
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.52.
Footnote F10
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.785.
Footnote F11
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.71.
Footnote F12
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.25 to $30.245.
Footnote F13
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.25 to $31.2475.
Footnote F14
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.25 to $31.61.
SEC remarks
(15) The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. (16) Scott M. Hendler is signing on behalf of Mr. Halvorsen, Mr. Ott and Ms. Shabet, each individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, as manager of DRAGSA 96 LLC and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to authorization and designation letters dated February 9, 2021, which were filed with the Securities and Exchange Commission on June 7, 2021.